Why the study?
Does an intravenous anti-inflammatory agent reduce mortality and morbidities in patients undergoing open abdominal aortic aneurysm repair?
Does an intravenous anti-inflammatory agent reduce mortality and morbidities in patients undergoing open abdominal aortic aneurysm repair?
Answers are grounded in this paper and cite their sources.
Intravenous anti-inflammatory agents may reduce mortality and morbidities following open abdominal aortic aneurysm repair.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nejim et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: